PZJ
- Product code
- PZJ
- Device name
- Lynch Syndrome Test System
- Device class
- Class 2
- 21 CFR
- 21 CFR 864.1866
- Medical specialty
- Immunology
- Marketing pathway
- 510(K)
- 510(k) clearances (all years, FDA)
- 4 (all years; only the last 3 years are listed here)
FDA classification definition
The Lynch syndrome test system is used to identify loss of DNA mismatch repair proteins or microsatellite instability in tumor tissue from cancer patients for the purpose of identifying patients who may benefit from additional testing for the inherited cancer predisposition Lynch Syndrome
Official FDA classification page: PZJ
Classification and pathway per current FDA publications. Data from openFDA (CC0).